Sign Up Today and Learn More About Attralus Stock
Invest in or calculate the value of your shares in Attralus or other pre-IPO companies through EquityZen's platform.
Attralus Stock (ATTR)
Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.
About Attralus Stock
Founded
2019
Headquarters
San Francisco, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Attralus Press Mentions
Stay in the know about the latest news on Attralus
Regulatory actions for Nov. 13, 2024
bioworld • Nov 15, 2024
Attralus Therapeutic AT-02 Receives Orphan Drug Designation from the U.S. FDA for the Treatment of ATTR Amyloidosis
globenewswire • Nov 12, 2024
Attralus Presents New Data on Its Pan-Amyloid Therapeutic
globenewswire • Aug 03, 2024
Attralus Presents New Data on Its Pan-Amyloid Therapeutic and Diagnostic Candidates at the XIX International ...
finance • Jul 02, 2024
Attralus Closes $56 Million Financing
globenewswire • May 05, 2024
Attralus Management
Leadership team at Attralus
Co-Founder & Interim Chief Scientific Officer
Jonathan Wall
Board Member
Richard Gaster
Join now and verify your accreditation status to gain access to:
- Attralus current valuation
- Attralus stock price
- Available deals in Attralus and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Attralus stock?
Accredited investors can buy pre-IPO stock in companies like Attralus through EquityZen funds. These investments are made available by existing Attralus shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Attralus stock?
Shareholders can sell their Attralus stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
